Long-term immunity study of chickenpox vaccine booster
Part of Infections clinical trials.
This study follows up people who were in a previous phase 3 chickenpox vaccine trial. It checks how long protection from a booster dose lasts, by taking a blood sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the earlier phase 3 chickenpox vaccine study.
- You or your guardian can understand and sign a consent form.
- You have a verified legal identity (like a government ID).
- You are still within the allowed blood collection time window.
- You have not had chickenpox or shingles since the earlier study.
- You have not received any other chickenpox vaccine since the earlier study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people who previously took a chickenpox (varicella) vaccine to see how long their immune protection lasts. It may help explain who stays protected over time and for how long.
This trial tests how safe and how well a live, weakened chickenpox (varicella) vaccine works in healthy people age 13 and older. If you qualify, you may receive the study vaccine and be monitored for side effects and immune response.
This study looks at how well the varicella (chickenpox) vaccine protects people who have been in close contact with someone who has chickenpox. It may help find better ways to prevent chickenpox in children.
This study gives a second chickenpox vaccine dose to healthy children who were vaccinated once before. It mainly checks safety and measures the body’s immune response to see how well the second dose works.
This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.
This study tests a new shingles vaccine to make sure each batch works the same way. If you are 40 or older and have never had shingles or the shingles vaccine, you may qualify.
Hear when a new Varicella trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.